Press coverage about Kewaunee Scientific (NASDAQ:KEQU) has trended positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kewaunee Scientific earned a media sentiment score of 0.26 on Accern’s scale. Accern also gave press coverage about the technology company an impact score of 44.2957090191611 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of Kewaunee Scientific (NASDAQ KEQU) remained flat at $$28.80 during trading hours on Tuesday. The company had a trading volume of 800 shares, compared to its average volume of 2,120. Kewaunee Scientific has a 1 year low of $20.95 and a 1 year high of $31.20. The company has a market cap of $78.35, a P/E ratio of 17.25 and a beta of 0.09. The company has a quick ratio of 1.58, a current ratio of 2.12 and a debt-to-equity ratio of 0.04.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings data on Tuesday, December 5th. The technology company reported $0.62 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 10.61% and a net margin of 3.28%. The company had revenue of $41.47 million during the quarter.

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 18th. Stockholders of record on Monday, December 4th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date of this dividend was Friday, December 1st. Kewaunee Scientific’s dividend payout ratio is presently 40.72%.

In other news, Director Donald F. Shaw acquired 2,000 shares of Kewaunee Scientific stock in a transaction dated Wednesday, December 27th. The stock was bought at an average price of $28.79 per share, for a total transaction of $57,580.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Donald F. Shaw acquired 888 shares of Kewaunee Scientific stock in a transaction dated Wednesday, December 26th. The shares were purchased at an average price of $28.78 per share, with a total value of $25,556.64. Following the acquisition, the director now owns 21,250 shares of the company’s stock, valued at $611,575. The disclosure for this purchase can be found here. Insiders own 20.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.

Insider Buying and Selling by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with's FREE daily email newsletter.